🇺🇸 Superoxide Dismutase in United States

11 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pain In Extremity — 2 reports (18.18%)
  2. Alpha 1 Globulin Increased — 1 report (9.09%)
  3. Alpha 2 Globulin Increased — 1 report (9.09%)
  4. Aortic Disorder — 1 report (9.09%)
  5. Arthralgia — 1 report (9.09%)
  6. Back Pain — 1 report (9.09%)
  7. Blood Glucose Increased — 1 report (9.09%)
  8. Bone Pain — 1 report (9.09%)
  9. Bursitis — 1 report (9.09%)
  10. Cardiac Disorder — 1 report (9.09%)

Source database →

Superoxide Dismutase in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Superoxide Dismutase approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Superoxide Dismutase in United States?

Yang I. Pachankis is the originator. The local marketing authorisation holder may differ — check the official source linked above.